Article info
Letter
Impaired long-term immune protection following pneumococcal 13-valent/23-valent polysaccharide vaccine in systemic lupus erythematosus (SLE)
- Correspondence to Professor Karim Sacre, Department of Internal Medicine, Bichat Hospital, APHP, Paris 75018, France; karim.sacre{at}bch.aphp.fr
Citation
Impaired long-term immune protection following pneumococcal 13-valent/23-valent polysaccharide vaccine in systemic lupus erythematosus (SLE)
Publication history
- Received December 4, 2017
- Revised February 5, 2018
- Accepted February 5, 2018
- First published February 14, 2018.
Online issue publication
April 20, 2023
Article Versions
- Previous version (1 July 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.